Respiratory Medicine
Volume 95, Issue 1 , Pages 48-55, January 2001

Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum-processing methods

  • T. METSO

      Affiliations

    • Skin and Allergy Hospital, Division of Allergy, Helsinki University, Helsinki, Finland
  • ,
  • P. RYTIL

      Affiliations

    • Skin and Allergy Hospital, Division of Allergy, Helsinki University, Helsinki, Finland
  • ,
  • C. PETERSON

      Affiliations

    • Asthma and Allergy Research, Pharmacia and Upjohn Diagnostics, Uppsala, Sweden
  • ,
  • T. HAAHTELA

      Affiliations

    • Skin and Allergy Hospital, Division of Allergy, Helsinki University, Helsinki, Finland

Received 7 April 2000; accepted 26 September 2000.

Abstract 

Induced sputum is increasingly used to detect and monitor airway inflammation in respiratory diseases. However, the processing of sputum has been rather laborious for clinical practice.

The aim of this study was to improve the practicality of induced-sputum studies by simplifying sample processing. Eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), neutrophil lipocalin (HNL) and myeloperoxidase (MPO) were used as biochemical markers of airway inflammation and the results of the study method were compared with a previously validated (reference) method.

Induced sputum was obtained from 42 healthy controls, 10 subjects with acute respiratory infection, eight patients with chronic obstructive pulmonary disease (COPD) and 17 asthmatics. The sputum sample was divided into two parts and treated either: (i) by the reference method (released markers), where sputum was homogenized with dithiotreitol and centrifuged to yield cell-free supernatant and a cell pellet, or (ii) by the study method (total markers), where the cells were lysed after homogenization so that cell-associated markers were released and solubilized. For comparison, the four biochemical markers were measured in sputum supernatant and in sputum lysate. The differential cell count was performed from the cell pellet in the reference method. Repeatability was assessed in a group of 16 subjects. The effect of reagents and the recovery of assays were also evaluated.

Released and total markers correlated well (ECP rs=0·80, P<0·0001; EPOrs =0·49, P<0·0001; HNLrs =0·87, P<0·0001; MPOrs =0·71, P<0·0001). Incubation with dithiotreitol and lysis reagent had no negative influence on marker assays. The within-subject variability of total ECP, MPO and HNL in both methods was small in two measurements taken 1 week apart.

The study method, measuring total inflammatory markers, gave comparable results to the reference method, measuring released markers. In the study method the sputum processing was simplified, which may improve its applicability.

Keywords: asthma, chronic obstructive pulmonary disease, eosinophil cationic protein, eosinophil peroxidase, induced sputum, infection, human neutrophil lipocalin, myeloperoxidase.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • f1 Correspondence should be addressed to: Tuula Metso, Skin and Allergy Hospital, Division of Allergy, Helsinki University Central Hospital, Meilahdentie 2, FIN-00250 Helsinki, Finland. Fax: +358-9-47186500; E-mail: tuula.metso@sci.fi

PII: S0954-6111(00)90970-3

doi:10.1053/rmed.2000.0970

Respiratory Medicine
Volume 95, Issue 1 , Pages 48-55, January 2001